Rallybio Ratios (2023-2025) | RLYB

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -5,267.22%-3,621.74%-530,700.00%-4,175.47%-4,441.51%7,554.72%
EBIT Margin -5,697.32%-4,035.45%-580,400.00%-4,561.32%-4,743.87%-3,266.51%
EBITDA Margin -5,430.10%-3,754.52%-557,250.00%-4,462.26%-4,591.04%7,558.02%
Operating Margin -5,697.32%-4,035.45%-580,400.00%-4,561.32%-4,743.87%-3,266.51%
Net Margin -5,267.22%-3,621.74%-530,700.00%-4,175.47%-4,441.51%7,554.72%
FCF Margin -3,484.28%-4,530.10%-493,100.00%-4,813.68%-3,952.36%-3,089.62%
Efficiency
Assets Average 154.95M140.38M124.41M107.49M95.89M85.72M73.56M63.05M54.49M59.33M
Equity Average 147.23M131.42M114.88M97.67M84.59M75.42M66.24M57.86M50.02M54.50M
Invested Capital 155.20M139.26M123.58M106.18M89.16M80.02M70.82M61.65M54.07M45.96M63.03M
Asset Utilization Ratio 0.000.010.010.010.010.01
Leverage & Solvency
Equity Ratio 0.960.940.930.920.900.870.900.910.930.900.93
Valuation
Enterprise Value -150.39M-137.84M-121.38M-109.93M-94.17M-88.61M-75.14M-65.51M-54.49M-45.75M-59.32M
Return Ratios
Return on Sales -52.67%-36.22%-5,307.00%-41.75%-44.42%75.55%
Return on Capital Employed -0.69%-0.82%-0.92%-0.90%-0.90%-0.85%-0.88%-0.70%
Return on Assets -0.58%-0.69%-0.75%-0.75%-0.76%-0.73%-0.73%-0.22%
Return on Equity -0.63%-0.76%-0.84%-0.86%-0.84%-0.80%-0.79%-0.24%